The emerging approach of this peptide represents a exciting development in the care of the condition. Distinct from existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide714630.webbuzzfeed.com/42366296/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment